Expected timeline to market If the TRIUMPH trials produce results consistent with Phase 2, regulatory submission could occur as early as late next year, with approval and market availability following twelve to eighteen months later
If you're already on semaglutide and tolerating it, adding a second medication with the same warning doesn't reduce your theoretical risk
In fact, DPP-4 inhibitors, aimed at elongating effect of endogenous incretins, are available for the treatment of type 2 diabetes though the glycemic effect of these medications are comparatively modest [24]
Whether youre on a weight loss journey or just want an extra health boost, were here to help
Its also used in chronic illness recovery and longevity protocols
The three potentially blinding eye conditions included NAION, papillitis, and paracentral acute middle maculopathy